We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
10 Year Est. Return
AUM
$700M
AUM Growth
-$4.98M
Cap. Flow
-$12M
Cap. Flow %
-1.71%
Top 10 Hldgs %
65.48%
Holding
53
New
8
Increased
9
Reduced
3
Closed
5

Sector Composition

1 Communication Services 25.8%
2 Consumer Discretionary 20.6%
3 Healthcare 12.96%
4 Technology 12.44%
5 Financials 11.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$276B
$122M 17.37%
704,382
AAPL icon
2
Apple
AAPL
$4.9T
$52.6M 7.51%
1,365,588
BAC icon
3
Bank of America
BAC
$430B
$52.4M 7.48%
2,066,982
-330,000
-14% -$8.01M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.23T
$50M 7.14%
1,028,000
META icon
5
Meta Platforms (Facebook)
META
$1.64T
$48.1M 6.86%
281,300
+24,000
+9% +$4.01M
DIS icon
6
Walt Disney
DIS
$170B
$38.8M 5.53%
393,230
IBB icon
7
iShares Biotechnology ETF
IBB
$9.23B
$28.8M 4.11%
259,050
BIDU icon
8
Baidu
BIDU
$36.5B
$26.7M 3.81%
107,757
-112,900
-51% -$24.6M
AGN
9
DELISTED
Allergan plc
AGN
$22.4M 3.2%
109,448
+13,800
+14% +$3.21M
XLE icon
10
State Street Energy Select Sector SPDR ETF
XLE
$38.2B
$17.2M 2.46%
502,560
C icon
11
Citigroup
C
$217B
$16.5M 2.36%
226,930
+125,000
+123% +$8.53M
JD icon
12
JD.com
JD
$40B
$16.3M 2.33%
426,835
+140,500
+49% +$6.01M
OLED icon
13
Universal Display
OLED
$3.75B
$15.7M 2.24%
121,994
+14,105
+13% +$1.71M
XLV icon
14
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$13.8M 1.97%
169,100
-121,000
-42% -$9.72M
BMY icon
15
Bristol-Myers Squibb
BMY
$124B
$11.9M 1.69%
186,000
CELG
16
DELISTED
Celgene Corp
CELG
$10.3M 1.48%
70,917
XBI icon
17
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$10.3M 1.47%
+119,000
New +$9.54M
MA icon
18
Mastercard
MA
$480B
$9.8M 1.4%
69,400
LMT icon
19
Lockheed Martin
LMT
$117B
$9.31M 1.33%
30,000
XLNX
20
DELISTED
Xilinx Inc
XLNX
$8.57M 1.22%
121,000
+45,000
+59% +$2.94M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.37M 1.19%
89,900
TMUS icon
22
T-Mobile US
TMUS
$208B
$8.18M 1.17%
132,600
+79,600
+150% +$4.99M
LBTYA icon
23
Liberty Global Class A
LBTYA
$3.52B
$8.05M 1.15%
237,371
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7.76M 1.11%
+250,000
New +$7.03M
BIIB icon
25
Biogen
BIIB
$30.4B
$7.51M 1.07%
24,000

Similar funds

NF Trinity Capital's Q3 2017 Portfolio in Review

As of Q3 2017, NF Trinity Capital held 53 positions worth $700M, down 0.71% from $705M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NF Trinity Capital's Q3 2017 filing shows 8 new, 9 increased, 3 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • NF Trinity Capital's largest Q3 2017 buy was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M.
  • NF Trinity Capital added most to Citigroup in Q3 2017, an estimated $8.53M increase.
  • NF Trinity Capital's biggest Q3 2017 reduction was Baidu, cutting an estimated $24.6M.
  • NF Trinity Capital fully exited Acadia Pharmaceuticals in Q3 2017, selling an estimated $5.72M.
  • NF Trinity Capital's ten largest holdings make up 65% of its $700M portfolio in Q3 2017.
  • NF Trinity Capital opened 8 new positions and closed 5 in Q3 2017.
  • NF Trinity Capital's portfolio value fell 0.71% quarter-over-quarter to $700M.

Based on NF Trinity Capital's 13F filing for Q3 2017, filed 7 Nov 2017.